Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 2838-2848

  Ro, Yuuki ^a   Hamada, Chieko ^a   Inaba, Masanori ^a   Io, Hiroaki ^a   Kaneko, Kayo ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cell infiltration; Continuous ambulatory peritoneal dialysis (CAPD); Matrix metalloproteinases (MMP); Sclerosing peritonitis

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; ALPHA SMOOTH MUSCLE ACTIN; CHLORHEXIDINE GLUCONATE; COLLAGEN TYPE 1; MATRIX METALLOPROTEINASE INHIBITOR; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLEROSING PERITONITIS; STATISTICAL SIGNIFICANCE;

ACTINS; ANIMALS; ANTI-INFECTIVE AGENTS; CHLORHEXIDINE; COLLAGEN TYPE I; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; PERITONEAL DIALYSIS; PERITONEUM; PHENYL ETHERS; RATS; RATS, SPRAGUE-DAWLEY; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 36048952125     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm323     Document Type: Article

References (20)

1. Gandhi VC, Humayan HM, Hano JE et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140: 1201-1203
2. Williams JD, Craig KJ, Topley N et al. Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
3. Mishima Y, Miyazaki M, Kohno S et al. Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Kidney Int 2003; 23: 14-22 1
4. Margetts PJ, Kolb M, Galt T et al. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12: 2029-2039
5. Io H, Ro Y, Tomino Y et al. Morphological changes of peritoneum and expression of VEGF in encapsulated sclerosis rat models. Kidney Int 2004; 65: 1927-1936
6. Hirahara I, Umeyama K, Asano Y et al. Increase of matrix metalloproteinase-2 in dialysate of rat sclerosing encapsulating peritoneal model. Nephrology 2002; 7: 161-169
7. Ro Y, Hamada C, Tomino Y et al. Early diagnosis of CAPD peritonitis using a test kit for detection of matrix metalloproteinase (MMP)-9. Perit Dial Int 2004; 24: 90-91
8. Hirahara I, Ogawa Y, Kusano E et al. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 2004; 19: 1732-1741
9. Corbel M, Caulet-Maugendre S, Boichot E et al. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J pathol 2001; 193: 538-545
10. Yamada A, Uegami A, Ogawa K et al. ONO-4817, an orally active matrix metalloproteinase inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs. Inflamm Res 2000; 49: 144-146
11. Muranishi Y, Mitani N, Sakai I et al. Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma. Anticancer Res 2001; 21: 3845-3852
12. Chomzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate. Anal Biochem 1987; 162: 156-159
13. Kobayashi N, Nakano S, Mori Y et al. Benidipine inhibits expression of ET-1 and TGF-beta1 in Dahl salt-sensitive hypertensive rats. Hypertens Res 2001; 24: 241-250
14. Hayashi K, Horikoshi S, Osada S et al. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis. J Pathol 2000; 191: 299-305
15. He JS, Hayashi K, Tomino Y et al. Identification of cellular origin of type I collagen in glomeruli of rats with crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody. Nephrol Dial Transplant 2001; 16: 704-711
16. Uchida Y, Sawada T, Nishihara T et al. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells. Pancreas 2004; 29: 123-131
17. Nathan C. Secretory products of macrophages. J Clin Invest 1987; 79: 319-326
18. Delcaux C, Delacourt C, d'Ortho MP et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cel Mol Biol 1996; 14: 288-295
19. Naito Y, Takagi T, Kuroda K et al. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextrin sulfate sodium-induced colitis in mice. Inflamm res 2004; 53: 462-468
20. Muraishi Y, Mitani N, Fuse H et al. Effect of a matrix metalloproteinase inhibitor in metastasis of murine renal cell carcinoma. Anticancer Res 2001; 21: 3845-3852